Advanced Search
Cao FengQin, . Observation on the effect of the plan of CA(E)P to treat non-small cell lung carcinoma[J]. Cancer Research on Prevention and Treatment, 1996, 23(1): 40-42.
Citation: Cao FengQin, . Observation on the effect of the plan of CA(E)P to treat non-small cell lung carcinoma[J]. Cancer Research on Prevention and Treatment, 1996, 23(1): 40-42.

Observation on the effect of the plan of CA(E)P to treat non-small cell lung carcinoma

More Information
  • Combined chemotherapy using to plan of CA (E)P that is cyclophosphamid,adviamycin, cisplatin to treat non-small cell lung carcinoma was studied. In 125cases, male 111 cases, female 14 cases. The median age was 53. 5 years (17-72years). adeno-carcinoma 89 cases, squamous carcinoma 36 cases. The tatal effectine rate is 52. 0% (65/125). There were no significant difference between the adeno-carcinoma group and the squamous carcinoma group.Using Myocardial Engyme spectrum to exame the cardiac toxic seaction of Adviamycin. There were nosignificant difference in all cases between before and after chemotherapy. In 18 cases who has changes in ECG before chemotherapy, ECG changes were advions. Thedifference was statistitly significant (P0. 01). It is suggested that the patientwith the change of ECG using chemotherapy of adviamycin and epirabicin must becautions.
  • 1. 孙燕.肺癌的化学治疗和综合治疗.肿瘤防治研究,1984, 11(2):108.
    2. 孙燕.肺癌治疗方法选择.中华结核和呼吸系统疾病,1986, 9(3):179.
    3. 廖美琳.肺癌扩大根治术指征限度.中华结核和呼吸系统疾病,1986. 9(3):179.
    4. 廖美琳.肺癌治疗近况和发展.国外医学肿瘤分册,1993, 20(4):217.
    5. A. X TpaxMeHfiep Jak uikolo lup uemoga leleHUl uockba uyganelbcmfo (uegHUHaI), 1987,240.
    6. 林道平.肺癌防治研究之进展·癌症,1989, 8(3):210.
    7. Nou. E. The Natural Five-year Course in Bronchial Carcinoma Epidemiologic Resule cancer, 1984. 53:2211.
    8. Repp. E, et al. Chemotherapy Can prolong Survival in patients with Advanced Non-small-cell lung Cancer Repport of a Canadi ian Multicerter Randomized Trial J. Clin oncol. 1988, 6:633.
    9. Eagan RT. et al. phase 1 stady of cyclophosphamide. Adriamycin, and cis-Dichlorodim mineplatinum(I) by infusion in patients with Adnocorcinoma and large cellCarcinoma of the lung. Cancer Treat Rep. 1979, 63:1589.
    10 Knost JA, et al. cyclophosphamide. Doxorubicin, and Cisplantin in the Treatment of advanced Non-small-cell lung Cancer. Cancer Treat Rep, 1981, 65:941.
    11 Evans WK. et al, cyclophosphamide, Doxorubicin an-dcisplantin in the treaement of Non-small-cell bronchegcnic Carcinoma. Cancer treat Rep, 1981, 65:947.
  • Related Articles

    [1]LI Xiaofeng, LIU Caiyun, SHI Yan, LUO Xiaohu, WANG Gang, YAO Biao. Differential Diagnosis of Benign and Malignant Breast Lesions by Texture Feature Combined with Histogram Parameter Based on Tirm Sequence[J]. Cancer Research on Prevention and Treatment, 2018, 45(12): 1009-1013. DOI: 10.3971/j.issn.1000-8578.2018.18.0815
    [2]ZHOU Ni'na, LI Nan, YU Jiangyuan, WANG Xuejuan, ZHU Hua, FAN Yang, YANG Zhi. Value of 18F-FDG Distribution for Differential Diagnosis of High Metabolic Lung Lesions[J]. Cancer Research on Prevention and Treatment, 2017, 44(12): 823-826. DOI: 10.3971/j.issn.1000-8578.2017.17.0302
    [3]YANG Bo-jun, CHANG Qing, YAN Yu-hu. Pathology and Differential Diagnosis of Extraskeletal Osteosarcoma-Attached 4 Cases Report and Literatures Review[J]. Cancer Research on Prevention and Treatment, 2010, 37(09): 1058-1061. DOI: 10.3971/j.issn.1000-8578.2010.09.022
    [4]LUO Yan-di. Differential Diagnosis Value of Color Doppler Ultrasound between Small Breast Cancer and Hyperplastic Nodule of Mammary Glands[J]. Cancer Research on Prevention and Treatment, 2010, 37(08): 935-937. DOI: 10.3971/j.issn.1000-8578.2010.08.020
    [5]SUN Xiao-min, DONG Wei-guo, YU Bao-ping, et al, . An explore of VEGF and sCD44v6 in the diagnosis and significiace of malignant ascites[J]. Cancer Research on Prevention and Treatment, 2003, 30(05): 370-372. DOI: 10.3971/j.issn.1000-8578.1430
    [6]DENG Zhi-hua, CAI Hong-pei, LI Shi, et al. Detection of telomerase activity is an important index for differential diagnosis between benign and malignant pleural effusion[J]. Cancer Research on Prevention and Treatment, 2002, 29(02): 87-89. DOI: 10.3971/j.issn.1000-8578.920
    [7]PENG Bin, WAN Jin-fang, LI Hui, PENG Shan-you. The Ultrasonic Differential Diagnosis and Pat-Hologic Study of Intraocular Tumor[J]. Cancer Research on Prevention and Treatment, 1999, 26(4): 290-291.
    [8]Ji Xiaolong, . Differential diagnosis between reactive follicular hyperplasia and follicular lymphoma[J]. Cancer Research on Prevention and Treatment, 1996, 23(3): 140-142.
    [9]Wang Zi-Bin, . Clinical Radiological Diagnosis of Pulmonary Carcinoma in Special Types[J]. Cancer Research on Prevention and Treatment, 1995, 22(4): 241-244.
    [10]Yang HongYing, . Quantitative analysis of Ag-NORs in histiocytic necrotizing lymphadenits differentiated diagnosis of non-hodgkin lymphomas[J]. Cancer Research on Prevention and Treatment, 1994, 21(6): 339-341.

Catalog

    Cao FengQin

    1. On this Site
    2. On Google Scholar
    3. On PubMed
    Article views (1593) PDF downloads (446) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return